HEADER TRANSFERASE 14-JAN-23 8I2N TITLE THE RIPK1 KINASE DOMAIN IN COMPLEX WITH QY7-2B COMPOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CELL DEATH PROTEIN RIP,RECEPTOR-INTERACTING PROTEIN 1,RIP-1; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: QY7-2B SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RIPK1, RIP, RIP1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS RIPK1, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR X.Y.GONG,Y.LI,H.Y.MENG,L.F.PAN REVDAT 1 31-JAN-24 8I2N 0 JRNL AUTH X.Y.GONG,Y.LI,H.Y.MENG,L.F.PAN JRNL TITL THE RIPK1 KINASE DOMAIN IN COMPLEX WITH QY7-2B COMPOUND JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.30 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 27467 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1345 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.3000 - 4.9200 1.00 2794 135 0.1849 0.2017 REMARK 3 2 4.9200 - 3.9100 1.00 2642 137 0.1765 0.1906 REMARK 3 3 3.9100 - 3.4100 1.00 2633 139 0.2058 0.2338 REMARK 3 4 3.4100 - 3.1000 1.00 2586 137 0.2460 0.3041 REMARK 3 5 3.1000 - 2.8800 1.00 2599 144 0.2748 0.3376 REMARK 3 6 2.8800 - 2.7100 1.00 2570 143 0.2550 0.2750 REMARK 3 7 2.7100 - 2.5700 1.00 2570 143 0.2599 0.2832 REMARK 3 8 2.5700 - 2.4600 1.00 2583 113 0.2638 0.3520 REMARK 3 9 2.4600 - 2.3700 1.00 2581 123 0.2691 0.2846 REMARK 3 10 2.3700 - 2.2900 1.00 2564 131 0.2662 0.3071 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.289 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.503 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 48.42 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 4442 REMARK 3 ANGLE : 1.719 5995 REMARK 3 CHIRALITY : 0.095 655 REMARK 3 PLANARITY : 0.011 761 REMARK 3 DIHEDRAL : 15.010 1671 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8I2N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 23-JAN-23. REMARK 100 THE DEPOSITION ID IS D_1300034770. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUL-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27550 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290 REMARK 200 RESOLUTION RANGE LOW (A) : 78.210 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 12.90 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.41 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.21600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 4ITJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM CHLORIDE, 0.1 M TRIS PH REMARK 280 7.9, 23% W/V POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.25500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.06450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 49.37100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.06450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.25500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 49.37100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLN A 2 REMARK 465 PRO A 3 REMARK 465 ASP A 4 REMARK 465 MET A 5 REMARK 465 SER A 6 REMARK 465 GLY A 26 REMARK 465 GLY A 27 REMARK 465 PHE A 28 REMARK 465 GLY A 29 REMARK 465 ARG A 177 REMARK 465 GLU A 178 REMARK 465 VAL A 179 REMARK 465 ASP A 180 REMARK 465 GLY A 181 REMARK 465 THR A 182 REMARK 465 ALA A 183 REMARK 465 LYS A 184 REMARK 465 LYS A 185 REMARK 465 ASN A 186 REMARK 465 MET B 1 REMARK 465 GLN B 2 REMARK 465 PRO B 3 REMARK 465 ASP B 4 REMARK 465 MET B 5 REMARK 465 SER B 6 REMARK 465 GLU B 22 REMARK 465 LEU B 23 REMARK 465 ASP B 24 REMARK 465 SER B 25 REMARK 465 GLY B 26 REMARK 465 GLY B 27 REMARK 465 PHE B 28 REMARK 465 GLY B 29 REMARK 465 LYS B 30 REMARK 465 GLU B 171 REMARK 465 GLU B 172 REMARK 465 HIS B 173 REMARK 465 ASN B 174 REMARK 465 GLU B 175 REMARK 465 LEU B 176 REMARK 465 ARG B 177 REMARK 465 GLU B 178 REMARK 465 VAL B 179 REMARK 465 ASP B 180 REMARK 465 GLY B 181 REMARK 465 THR B 182 REMARK 465 ALA B 183 REMARK 465 LYS B 184 REMARK 465 LYS B 185 REMARK 465 ASN B 186 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 30 CG CD CE NZ REMARK 470 LYS B 13 CG CD CE NZ REMARK 470 ARG B 37 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 49 CG CD CE NZ REMARK 470 LYS B 87 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 264 CA - CB - CG ANGL. DEV. = 10.9 DEGREES REMARK 500 MET B 92 O - C - N ANGL. DEV. = -9.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 56 59.04 -92.64 REMARK 500 ASP B 200 73.17 -155.13 REMARK 500 REMARK 500 REMARK: NULL DBREF 8I2N A 1 294 UNP Q13546 RIPK1_HUMAN 1 294 DBREF 8I2N B 1 294 UNP Q13546 RIPK1_HUMAN 1 294 SEQADV 8I2N ALA A 34 UNP Q13546 CYS 34 ENGINEERED MUTATION SEQADV 8I2N ALA A 127 UNP Q13546 CYS 127 ENGINEERED MUTATION SEQADV 8I2N ALA A 233 UNP Q13546 CYS 233 ENGINEERED MUTATION SEQADV 8I2N ALA A 240 UNP Q13546 CYS 240 ENGINEERED MUTATION SEQADV 8I2N ALA B 34 UNP Q13546 CYS 34 ENGINEERED MUTATION SEQADV 8I2N ALA B 127 UNP Q13546 CYS 127 ENGINEERED MUTATION SEQADV 8I2N ALA B 233 UNP Q13546 CYS 233 ENGINEERED MUTATION SEQADV 8I2N ALA B 240 UNP Q13546 CYS 240 ENGINEERED MUTATION SEQRES 1 A 294 MET GLN PRO ASP MET SER LEU ASN VAL ILE LYS MET LYS SEQRES 2 A 294 SER SER ASP PHE LEU GLU SER ALA GLU LEU ASP SER GLY SEQRES 3 A 294 GLY PHE GLY LYS VAL SER LEU ALA PHE HIS ARG THR GLN SEQRES 4 A 294 GLY LEU MET ILE MET LYS THR VAL TYR LYS GLY PRO ASN SEQRES 5 A 294 CYS ILE GLU HIS ASN GLU ALA LEU LEU GLU GLU ALA LYS SEQRES 6 A 294 MET MET ASN ARG LEU ARG HIS SER ARG VAL VAL LYS LEU SEQRES 7 A 294 LEU GLY VAL ILE ILE GLU GLU GLY LYS TYR SER LEU VAL SEQRES 8 A 294 MET GLU TYR MET GLU LYS GLY ASN LEU MET HIS VAL LEU SEQRES 9 A 294 LYS ALA GLU MET SER THR PRO LEU SER VAL LYS GLY ARG SEQRES 10 A 294 ILE ILE LEU GLU ILE ILE GLU GLY MET ALA TYR LEU HIS SEQRES 11 A 294 GLY LYS GLY VAL ILE HIS LYS ASP LEU LYS PRO GLU ASN SEQRES 12 A 294 ILE LEU VAL ASP ASN ASP PHE HIS ILE LYS ILE ALA ASP SEQRES 13 A 294 LEU GLY LEU ALA SER PHE LYS MET TRP SER LYS LEU ASN SEQRES 14 A 294 ASN GLU GLU HIS ASN GLU LEU ARG GLU VAL ASP GLY THR SEQRES 15 A 294 ALA LYS LYS ASN GLY GLY THR LEU TYR TYR MET ALA PRO SEQRES 16 A 294 GLU HIS LEU ASN ASP VAL ASN ALA LYS PRO THR GLU LYS SEQRES 17 A 294 SER ASP VAL TYR SER PHE ALA VAL VAL LEU TRP ALA ILE SEQRES 18 A 294 PHE ALA ASN LYS GLU PRO TYR GLU ASN ALA ILE ALA GLU SEQRES 19 A 294 GLN GLN LEU ILE MET ALA ILE LYS SER GLY ASN ARG PRO SEQRES 20 A 294 ASP VAL ASP ASP ILE THR GLU TYR CYS PRO ARG GLU ILE SEQRES 21 A 294 ILE SER LEU MET LYS LEU CYS TRP GLU ALA ASN PRO GLU SEQRES 22 A 294 ALA ARG PRO THR PHE PRO GLY ILE GLU GLU LYS PHE ARG SEQRES 23 A 294 PRO PHE TYR LEU SER GLN LEU GLU SEQRES 1 B 294 MET GLN PRO ASP MET SER LEU ASN VAL ILE LYS MET LYS SEQRES 2 B 294 SER SER ASP PHE LEU GLU SER ALA GLU LEU ASP SER GLY SEQRES 3 B 294 GLY PHE GLY LYS VAL SER LEU ALA PHE HIS ARG THR GLN SEQRES 4 B 294 GLY LEU MET ILE MET LYS THR VAL TYR LYS GLY PRO ASN SEQRES 5 B 294 CYS ILE GLU HIS ASN GLU ALA LEU LEU GLU GLU ALA LYS SEQRES 6 B 294 MET MET ASN ARG LEU ARG HIS SER ARG VAL VAL LYS LEU SEQRES 7 B 294 LEU GLY VAL ILE ILE GLU GLU GLY LYS TYR SER LEU VAL SEQRES 8 B 294 MET GLU TYR MET GLU LYS GLY ASN LEU MET HIS VAL LEU SEQRES 9 B 294 LYS ALA GLU MET SER THR PRO LEU SER VAL LYS GLY ARG SEQRES 10 B 294 ILE ILE LEU GLU ILE ILE GLU GLY MET ALA TYR LEU HIS SEQRES 11 B 294 GLY LYS GLY VAL ILE HIS LYS ASP LEU LYS PRO GLU ASN SEQRES 12 B 294 ILE LEU VAL ASP ASN ASP PHE HIS ILE LYS ILE ALA ASP SEQRES 13 B 294 LEU GLY LEU ALA SER PHE LYS MET TRP SER LYS LEU ASN SEQRES 14 B 294 ASN GLU GLU HIS ASN GLU LEU ARG GLU VAL ASP GLY THR SEQRES 15 B 294 ALA LYS LYS ASN GLY GLY THR LEU TYR TYR MET ALA PRO SEQRES 16 B 294 GLU HIS LEU ASN ASP VAL ASN ALA LYS PRO THR GLU LYS SEQRES 17 B 294 SER ASP VAL TYR SER PHE ALA VAL VAL LEU TRP ALA ILE SEQRES 18 B 294 PHE ALA ASN LYS GLU PRO TYR GLU ASN ALA ILE ALA GLU SEQRES 19 B 294 GLN GLN LEU ILE MET ALA ILE LYS SER GLY ASN ARG PRO SEQRES 20 B 294 ASP VAL ASP ASP ILE THR GLU TYR CYS PRO ARG GLU ILE SEQRES 21 B 294 ILE SER LEU MET LYS LEU CYS TRP GLU ALA ASN PRO GLU SEQRES 22 B 294 ALA ARG PRO THR PHE PRO GLY ILE GLU GLU LYS PHE ARG SEQRES 23 B 294 PRO PHE TYR LEU SER GLN LEU GLU HET O4U A 301 36 HET O4U B 301 36 HETNAM O4U ~{N}-METHYL-1-[4-[[[1-METHYL-5-(PHENYLMETHYL)PYRAZOL-3- HETNAM 2 O4U YL]CARBONYLAMINO]METHYL]PHENYL]BENZIMIDAZOLE-5- HETNAM 3 O4U CARBOXAMIDE FORMUL 3 O4U 2(C28 H26 N6 O2) FORMUL 5 HOH *66(H2 O) HELIX 1 AA1 LYS A 13 SER A 15 5 3 HELIX 2 AA2 HIS A 56 ASN A 68 1 13 HELIX 3 AA3 ASN A 99 LYS A 105 1 7 HELIX 4 AA4 PRO A 111 LYS A 132 1 22 HELIX 5 AA5 LYS A 140 GLU A 142 5 3 HELIX 6 AA6 PHE A 162 ASN A 170 1 9 HELIX 7 AA7 ALA A 194 LEU A 198 5 5 HELIX 8 AA8 THR A 206 ASN A 224 1 19 HELIX 9 AA9 ALA A 233 SER A 243 1 11 HELIX 10 AB1 ASP A 248 ILE A 252 5 5 HELIX 11 AB2 PRO A 257 TRP A 268 1 12 HELIX 12 AB3 ASN A 271 ARG A 275 5 5 HELIX 13 AB4 THR A 277 LEU A 293 1 17 HELIX 14 AB5 LYS B 13 PHE B 17 5 5 HELIX 15 AB6 HIS B 56 ASN B 68 1 13 HELIX 16 AB7 LEU B 100 ALA B 106 1 7 HELIX 17 AB8 PRO B 111 LYS B 132 1 22 HELIX 18 AB9 LYS B 140 GLU B 142 5 3 HELIX 19 AC1 PHE B 162 ASN B 169 1 8 HELIX 20 AC2 GLY B 187 MET B 193 5 7 HELIX 21 AC3 ALA B 194 LEU B 198 5 5 HELIX 22 AC4 THR B 206 ASN B 224 1 19 HELIX 23 AC5 ALA B 233 SER B 243 1 11 HELIX 24 AC6 ASP B 248 ILE B 252 5 5 HELIX 25 AC7 PRO B 257 TRP B 268 1 12 HELIX 26 AC8 ASN B 271 ARG B 275 5 5 HELIX 27 AC9 THR B 277 LEU B 293 1 17 SHEET 1 AA1 6 ILE A 10 MET A 12 0 SHEET 2 AA1 6 LEU A 78 GLU A 84 1 O VAL A 81 N MET A 12 SHEET 3 AA1 6 LYS A 87 GLU A 93 -1 O VAL A 91 N GLY A 80 SHEET 4 AA1 6 GLY A 40 LYS A 49 -1 N ILE A 43 O MET A 92 SHEET 5 AA1 6 VAL A 31 HIS A 36 -1 N ALA A 34 O MET A 42 SHEET 6 AA1 6 PHE A 17 GLU A 22 -1 N LEU A 18 O PHE A 35 SHEET 1 AA2 2 ILE A 144 VAL A 146 0 SHEET 2 AA2 2 ILE A 152 ILE A 154 -1 O LYS A 153 N LEU A 145 SHEET 1 AA3 4 SER B 32 HIS B 36 0 SHEET 2 AA3 4 GLY B 40 TYR B 48 -1 O GLY B 40 N HIS B 36 SHEET 3 AA3 4 LYS B 87 MET B 92 -1 O MET B 92 N ILE B 43 SHEET 4 AA3 4 LEU B 78 GLU B 84 -1 N GLU B 84 O LYS B 87 SHEET 1 AA4 3 GLY B 98 ASN B 99 0 SHEET 2 AA4 3 ILE B 144 VAL B 146 -1 O VAL B 146 N GLY B 98 SHEET 3 AA4 3 ILE B 152 ILE B 154 -1 O LYS B 153 N LEU B 145 CRYST1 46.510 98.742 128.129 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021501 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010127 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007805 0.00000